JOSHUA HELLER: Open Payments
NPI 1548442353 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,880 in 81 payments from 8 companies in 2025. Trend: 2023 $1,413 · 2024 $1,599 · 2025 $1,880
Food & beverage: $1,880
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 16 | $463 |
| Otsuka America Pharmaceutical, Inc. | 27 | $395 |
| E.R. Squibb & Sons, L.L.C. | 17 | $307 |
| Neurocrine BioSciences, Inc. | 5 | $255 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $150 |
| ABBVIE INC. | 5 | $122 |
| Teva Pharmaceuticals USA, Inc. | 4 | $105 |
| Janssen Pharmaceuticals, Inc | 3 | $83 |
Products named: ARISTADA, COBENFY, REXULTI, INGREZZA, CAPLYTA, VRAYLAR, UZEDY, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
